Evidence map›Paper›PMID 10559381›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1999

Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway.

I E Mazzoni, F A Saïd, R Aloyz, F D Miller, D Kaplan

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02141035 (Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome; a Randomized Control Trial.), which is not on this map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02141035 phase2 / phase3completednot on this mapstarted 2015, after this paper: background citation

Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome; a Randomized Control Trial.

TypeinterventionalSponsorUniversity of AlbertaRan2015 to 2017Enrolled20ConditionsCarpal Tunnel Syndrome, Compression NeuropathyArmsAcetyl-l-carnitine, placebo
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 146 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Proneurotrophins, seizures, and neuronal apoptosis.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2010
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Brain-derived neurotrophic factor: role in depression and suicide.Neuropsychiatric disease and treatment · 2009
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Neurotrophin-regulated signalling pathways.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2006
    Review
  19. Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

I E MazzoniCenter for Neuronal Survival, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4.
F A Saïd
R Aloyz
F D Miller
D Kaplan
Différenciation et Communication Neuronale et Neuroendocrine · FRMontreal Neurological Institute and Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this report, we examine how the Ras protein regulates neuronal survival, focusing on sympathetic neurons. Adenovirus-expressed constitutively activated Ras (RasV12) enhanced survival and the phosphorylation of Akt (protein kinase B) and MAP kinase (MAPK), two targets of Ras activity. Functional inhibition of endogenous Ras by adenovirus-expressed dominant-inhibitory Ras (N17Ras) decreased nerve growth factor (NGF)-dependent survival and both Akt and MAPK phosphorylation as well. To determine the signaling pathways through which Ras mediates survival, we used Ras effector mutants and pharmacological inhibitors that selectively suppress phosphatidylinositol 3-kinase (PI3-K)/Akt or MAP kinase kinase (MEK)/MAPK pathways. The Ras effector mutant Ras(V12)Y40C, which selectively stimulates PI3-K and Akt, rescued survival in the absence of NGF, and the PI3-K inhibitor LY 294002 inhibited both Ras- and NGF-dependent survival. Ras(V12)T(35)S, which activates MEK/MAPK but not PI3-K/Akt, was less effective at rescuing survival, whereas the MEK inhibitor PD 098059 also partially suppressed Ras-dependent survival. To investigate the mechanisms by which Ras suppresses neuronal death, we examined whether Ras functions by inhibiting the proapoptotic p53 pathway (Jun-N-terminal kinase/p53/BAX) that is necessary for neuronal death after NGF withdrawal and p75NTR activation. We found that RasV12 suppressed c-jun, BAX, and p53 levels, whereas inhibition of NGF-induced Ras-survival activity via N17Ras increased the levels of these proteins. Furthermore, the E1B55K protein, which suppresses p53 activity, blocked N17Ras-induced neuronal death. Together, these results indicate that Ras is, in part, both necessary and sufficient for survival of sympathetic neurons and that this effect is mediated by activation of both the PI3-K- and MEK-signaling cascades, which in turn suppress a proapoptotic p53 pathway.

Indexed as

Protein Serine-Threonine KinasesAdenoviridaeAnimalsAnimals, NewbornApoptosisCells, CulturedCell SurvivalMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesNerve Growth FactorsNeuronsPhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene ProteinsProto-Oncogene Proteins c-aktras ProteinsAkt1 protein, ratMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesNerve Growth FactorsPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktras ProteinsRecombinant ProteinsTumor Suppressor Protein p53

Identifiers

PMID10559381
PMCPMC6782948
OpenAlexW1545645579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.